Russia’s Sputnik V Vaccine Developer Stands Up for Its Reliability

Source: Sputnik V Official website

The Russian coronavirus vaccine Sputnik V was thoroughly tested, within a mechanism that was later picked up by major producers of foreign vaccines, Alexander Gintsburg, the head of the Gamaleya Institute of Epidemiology and Microbiology, told Sputnik on Tuesday.

Sputnik V was the world’s first coronavirus vaccine officially registered for emergency use on 11 August. Clinical trials ended in November, with an efficacy level of 91.4 percent,┬ábased on data from the first 16,000 trial participants that received both shots of the two-dose vaccine.

“Our vaccine has been tested more than enough. Mind that both Moderna and AstraZeneca followed our path,” Gintsburg said.

According to researchers, Sputnik V is capable of building up immunity for more than two years.